# Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study

> **NCT03022708** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Xeltis** · enrollment: 56 (estimated)

## Conditions studied

- Heart Defect, Congenital

## Interventions

- **DEVICE:** Xeltis Bioabsorbable Pulmonary Valved Conduit

## Key facts

- **NCT ID:** NCT03022708
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-05-08
- **Primary completion:** 2022-12-15
- **Final completion:** 2026-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022708, "Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03022708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*